jump to search | jump to navigation

Vitamin D critical in activating first-line immune defence

08.03.10 Copenhagen – Danish Scientists have established that activation of the first-line defence of our immune system depends on Vitamin D, and that without sufficient intake of the vitamin, T cells (killer cells) cannot react to and... more
 

Novo Nordisk wins US approval for somatropin drug

05.03.10 Bagsvaerd -- Novo Nordisk will enter the US market in Q2 of 2010 with Norditropin® FlexPro®, a somatropin pre-filled injection pen for children and adults with growth hormone disorders, after the FDA approved marketing of the... more
 

TopoTarget licences blood cancer drug to Spectrum

04.02.10 Copenhagen/Irvine – Danish TopoTarget A/S has granted Spectrum Pharmaceuticals Inc the rights to market its blood cancer blockbuster drug candidate, Belinostat, in North America, India and China. Under terms of the agreement,... more
 

Finland invests into novel EU life sciences infrastructure

04.02.10 Helsinki –Finland is investing EUR1.9m in creating world class bioinformatics, biobanking and translational research infrastructures. The investment comes as part of the linkage of three large EU projects ELIXIR, BBMRI, and... more
 

LEO Pharma’s PEP005 meets endpoint in Phase III trial

02.02.10 Ballerup – Danish dermatology specialist LEO Pharma announced yesterday that its topical treatment PEP005 (ingenol mebutate) for actinic keratosis (AK) has met the primary endoint of of complete clearance of body AK lesions in a... more
 

Metanavigation